Taken together, the changes in the tumor immune profile across multiple cancer models suggest that COUP-TFII-driven capillary-to-venule reprogramming selectively promoted the infiltration of T cells into the tumor tissue. This evidence concerns the gene NR2F2 and neoplasm.